5-9629548-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019599.3(TAS2R1):āc.485A>Cā(p.Gln162Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,976 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_019599.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R1 | ENST00000382492.4 | c.485A>C | p.Gln162Pro | missense_variant | 1/1 | 6 | NM_019599.3 | ENSP00000371932.2 | ||
TAS2R1 | ENST00000514078.1 | c.365A>C | p.Gln122Pro | missense_variant | 2/2 | 3 | ENSP00000476190.1 | |||
ENSG00000248525 | ENST00000504182.2 | n.36-5946A>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251032Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135722
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461676Hom.: 1 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 727148
GnomAD4 genome AF: 0.000112 AC: 17AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 16, 2024 | The c.485A>C (p.Q162P) alteration is located in exon 1 (coding exon 1) of the TAS2R1 gene. This alteration results from a A to C substitution at nucleotide position 485, causing the glutamine (Q) at amino acid position 162 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at